YKL-40: a Potential Biomarker and Therapeutic Target for Breast Cancer Diagnosis and Therapy
Rong Shao · Journal of Advances in Medicine and Medical Research · 2012
Over the past two decades, emerging data have found that YKL-40, a secreted glycoprotein, is elevated in a broad spectrum of human diseases including cancers, liver injury, asthma, diabetes, inflammatory diseases, and cardiac disorders. In breast cancer, increased serum levels of...
Open access
Research Article
10.9734/BJMMR/2012/1282